2012
DOI: 10.1016/j.jns.2011.09.027
|View full text |Cite
|
Sign up to set email alerts
|

Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0
2

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 39 publications
(33 citation statements)
references
References 39 publications
(72 reference statements)
1
30
0
2
Order By: Relevance
“…The trophic factors released from MSCs, in addition to the growth-sustaining extracellular matrix provided by the transplant, may also be capable of promoting regeneration of axons into, or beyond, the scar tissue produced by the injury (Kadoya et al, 2009). The identification of the ability for MSCs to secrete trophic factors as a mechanism to support recovery has led to the initiation of studies that utilize genetic engineering of MSCs to enhance the release of important molecules in attempts to further mitigate secondary injury cascades and promote cellular survival (Crane, Rossignol, & Dunbar, 2014;Dey et al, 2010;Ruitenberg et al, 2005;Sasaki et al, 2009;Shang et al, 2011;Zhang et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…The trophic factors released from MSCs, in addition to the growth-sustaining extracellular matrix provided by the transplant, may also be capable of promoting regeneration of axons into, or beyond, the scar tissue produced by the injury (Kadoya et al, 2009). The identification of the ability for MSCs to secrete trophic factors as a mechanism to support recovery has led to the initiation of studies that utilize genetic engineering of MSCs to enhance the release of important molecules in attempts to further mitigate secondary injury cascades and promote cellular survival (Crane, Rossignol, & Dunbar, 2014;Dey et al, 2010;Ruitenberg et al, 2005;Sasaki et al, 2009;Shang et al, 2011;Zhang et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…7 Stem cell transplantation is a promising candidate to treat SCI. [8][9][10][11][12] Recent work showed that stem cells, such as mesenchymal stem cells (MSCs), [13][14][15] neural stem/progenitor cells (NS/ PCs), 16,17 and embryonic stem cells (ESCs), [18][19][20] have immunoregulatory capacity and anti-inflammatory effects and could enhance functional improvement through inducing macrophages M1/M2 phenotype transformation post SCI. This review will discuss 1) the general feature of macrophages in response to SCI, 2) the phenotype and function of macrophages in SCI, and 3) the effects of stem cells on macrophage polarization and its role in stem cell-based therapies for SCI.…”
Section: Introductionmentioning
confidence: 99%
“…Loss of oligodendrocytes and myelin results in severe functional impairment [33,34]. Some studies also support the key role of remyelination in promoting neuronal survival after adult CNS injury [35,36].…”
Section: Discussionmentioning
confidence: 89%